+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 25Years - 50Years
All Genders
ID07526051

Comparing Autogenic Inhibition and Reciprocal Inhibition Techniques for Treating Lower Cross Syndrome in Adults Aged 25 to 50

Led by Foundation University Islamabad · Updated on 2026-05-20

72

Participants Needed

1

Research Sites

2 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to compare two physiotherapy techniques, autogenic inhibition PFS and reciprocal inhibition, in people with lower cross syndrome, a condition involving muscle imbalances in the lower back and hips. The study evaluates how these methods affect pain, functional disability, muscle strength, and range of motion in the lumbar spine and hips. Participants are randomly assigned to one of two groups. Group A receives the autogenic inhibition technique, which includes 10 minutes of TENS and heating pad application followed by stretching and strengthening exercises for the hip extensors and core muscles. Group B receives the reciprocal inhibition technique with similar TENS, heating, stretching, and strengthening exercises. Both groups participate in 12 sessions over four weeks, with three sessions each week. During the study, participants are assessed at baseline, the second week, and the fourth week for lumbar and hip range of motion, functional disability, pain intensity, and muscle strength using tools like VAS, ODI, sphygmomanometer, inclinometer, and goniometer. The total treatment time per session is about 30 minutes, and researchers monitor changes in physical function and pain over the treatment period.

CONDITIONS

Brief Title

Effects of Autogenic Inhibition Versus Reciprocal Inhibition in Individuals With Lower Cross Syndrome

Research Team

Z

Zobia Noor, DPT

R

Ruqia Begum, MS-OMPT

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here